Approvals/TGA/APO-MESALAZINE MR mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack

Approved

STANDARD

APO-MESALAZINE MR mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack

Southern Cross Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3ae4bd526bcb9b41
Product Name: APO-MESALAZINE MR mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack
Artg Id: 310309
Artg Name: APO-MESALAZINE MR mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack
Sponsor: Southern Cross Pharma Pty Ltd
Company Detail Path: /organization/southern-cross-pharma-pty-ltd
Artg Date: 2021-09-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3ae4bd526bcb9b41

Type

Standard